Thanks Cliff. As we have done in the past, we're reporting both GAAP and non-GAAP numbers. The reconciliations are in our filings and in the appendix of the presentation. Let's turn to Slide 5. I want to highlight again the progress that we're making towards our $1 billion of deployable capital exiting 2025 that we've previously laid out for you in our investor events and earnings updates. We've made significant progress with rationalizing our portfolio. During the quarter, we completed the second and final tranches of the benefit wallet transfer receiving the remainder of the $425 million of proceeds. The curbside and public safety divestiture closed on April 30 for which we received $174 million at closed with a further $61 million deferred over the next nine months. Also in the quarter, we announced the sale of our casualty claims solutions business for a price of $240 million subject to certain purchase price adjustments, which we anticipate will close later in Q3. These combined proceeds along with an updated and more favorable view on the tax drag associated with these divestitures puts us in the upper quartile of the $600 million to $800 million of targeted net proceeds. To date of the $1 billion of targeted deployable capital, we've deployed around 66% or $660 million against debt prepayment and share repurchases. During the quarter, we prepaid $300 million of our term loan B and repurchased approximately 43.3 million shares. I'll cover more detail on this later in my presentation. Suffice to say, we're where we said we'd be vis a vis this key component of our overall strategy. We've made significant strides in reducing our debt against a business that was traditionally too highly levered and even post these initial divestitures, Conduent retains a rich portfolio of assets that we continue to believe have strategic value, and Cliff will talk about a number of different aspects of that later in the call, but first, let's get through the earnings part of the narrative. Our reported numbers have started to deviate from the guide that we laid out at the beginning of the year because of the two closed divestitures and so consistent with the approach I outlined then, we are reporting Q2 numbers on an adjusted basis fully backing out the divestitures as well as providing a guide for the remainder of 2024 for adjusted revenue and adjusted EBITDA. I'll also give you our expectations as to how this will look for Q3 consistent with our past practice of guiding the upcoming quarter. We have published a full set of historical adjusted financials in our investor metrics file, which you will find in the Investors Section of the Conduent website. In our Q3 earnings, we'll likely be updating our full year guidance once more to adjust for the closure of the Casualty Claims Solutions business. It's important to note here once again that we will continue to work on the removal of stranded costs through 2024 and into 2025, and so the annualization of these won't be fully reflected in our numbers until the back end of 2025. Finally, we'll continue to provide you with an updated walk to our 2025 exit rates, so you can bridge between our actuals, our 2024 adjusted guide and the 2025 exit rate outlook we've laid out. Let's get into the slides, turning to Slide 6 and reviewing our key sales metrics. As you look at all of the sales metrics on Slide 6 and 7, it's important to note that we've adjusted all of these to exclude the two completed divestitures. As I prefaced in Q1 earnings, Q2 sales rebounded from the soft start to the year with ACV coming in at $142 million as compared to $97 million in Q1 $205 million in Q2 2023. As a reminder, Q2023 was the quarter in which we signed the State of Victoria transit deal, which contributed about $65 million of ACV and over $1 billion of TCV. While pleased with our rebound in Q2 sales, we're looking to continue improvement in the second half of the year. Adjusted for the effect of the two completed divestitures, we're expecting a full year outcome of between $525 million and $575 million of ACV. We have some bigger deals in our public sector markets during the second half, where precision in predicting timing can be an issue. Within commercial, we're expecting to see the strong second quarter continue into the second half of the year. Double clicking on the Q2 ACV number as I stated last quarter, we see renewed urgency to address cost and drive technology upgrades and business transformation through outsourcing both in the CX and BPaaS spaces where we play strongly with a broad set of offerings. This translated to strong Q2 ACV sales attainment in our commercial segment of $82 million of ACV. We had an encouraging start to the third quarter and we're making some targeted investments to expand delivery capacity in some of our strategic global locations. Our Government and Transportation segments achieved strong add on business from our existing clients, which drove an increase in NRR in the quarter. The Government Healthcare business continues to have a strong pipeline relating to the requirements for states to modernize and modularize their Medicaid technology environments. Turning to Slide 7, we've covered many of the metrics on the previous slide, but just a couple of extra pointers here to comment on. The net ARR activity metric turned negative this quarter consistent with how I messaged in last quarter's earnings at negative $49 million. Adjusted for the two closed divestitures, we expect the metric to stand at around $80 million to $90 million by the end of 2024 with a recovery to a positive number in the third quarter. The reason that it was negative in the quarter as I said previously is that there was pronounced asymmetry in our notified losses last year with them being far more weighted to the back half of the year. These rollouts with the trailing 12-month view in the coming quarters and additionally, we have confidence in the sales pipeline for the remainder of 2024. And really that's what's driving this porpoising effect that you're going to see in this metric while this asymmetry remains. Now let's turn to Slide 8 and discuss our Q2 2024 financial results. Adjusted revenue for Q2 2024 was $811 million as compared to $851 million in Q2 2023, down 4.7% year-over-year and down 4.6% on a constant currency basis slightly ahead of our internal expectations. I'll cover the segment level detail in a minute, but the overall view is that we continue to make progress in our Commercial and Transportation segments. However, the trajectory of recovery in our Government segment will continue into 2025. Adjusted EBITDA was $29 million for the quarter as compared to $64 million in Q2 2023 and the adjusted EBITDA margin was 3.6% for the quarter as compared to 7.5% in Q2 2023. This conforms to the low single-digit margin I guided for Q2. We're anticipating a sequential climb now each quarter as we progress through the remainder of 2024 and into 2025 and the drivers of this are threefold. Firstly, the cost efficiency work that we built into our original 2024 guide to compensate for the losses and contract roll offs naturally have more impact as we get deeper into the year and continue to add incremental benefit in 2025 as they annualize. We're in good shape with these cost efficiency programs with over 90% of the target having been actioned as we head into the second half of the year. These cost efficiency programs were baked into how we originally built our 2024 guide of an 8% to 9% adjusted EBITDA margin and we'd still be in that range without taking out these divestitures, albeit probably at the low end of that range. Secondly, you've got our stranded cost and additional margin expansion work, which we're just getting into. We're anticipating around $15 million of that $100 million to manifest in 2024 with more in 2025 and clearly annualizing to that $100 million as we exit 2025 consistent with how we laid out the walk for you in our exit rate outlook that we've been sharing. Finally, there's a little bit more revenue in the third quarter and especially the fourth quarters from ramp and open enrollment in our healthcare verticals. So now let's turn to Slide 9 and go over the segment results. For Q2 2024, commercial segment adjusted revenues were $425 million down 3.8% as compared to Q2 2023. The top line story for the commercial segment this quarter continues to be one of working off the effect of some prior year lost business. We still expect the growth gap to narrow due to improving sales performance and retention and the segment coming closer to flat as we exit 2024. Adjusted EBITDA for the commercial segment in Q2, 2024 was $41 commercial segment down 12.8% as compared to Q2 2023 and the adjusted EBITDA margin of 9.6% was down 100 basis points year-over-year driven by the impact of losses and some volume fluctuation. As a reminder, commercial segment EBITDA margins have reset due to the high-margin nature of the benefit wallet business we divested, which is now not in these adjusted numbers. Obviously, you'll recall that this business was totally dependent on high interest rates. Over time, this will be offset through our work to remove stranded costs, other operational efficiencies and improved operating margin as well as margin mix as the segment begins to move towards growth. We expect some modest sequential improvements to EBITDA margin as we move through the next few quarters. For the Government segment, Q2 2024 Revenues were $245 million down 9. 3% as compared to Q2 2023. The decreases you see this quarter and as we progress and lap them going into 2025 are driven by three very discrete items. Firstly, there's the effect of the government healthcare contract we referenced in February, where the contract was terminated for reasons other than performance. We'd hope to retain some scope of work there, but that didn't materialize and so the revenue ran off the end of the first quarter. The effect then in Q2 is approximately 4.5 points of the 9.3% year-over-year decline. In Q3, this is going to be approximately six points of decline and in Q4 five points of decline both as compared to prior year. This effect is then lapped as we move into 2025. Secondly, there's lower SNAP volumes in our government payments business as fewer states continue with the supplemental programs due to the change in funding structure as well as a lost client. This is about two to three points of revenue decline in the quarter and when compared against prior year for the remaining quarters of 2024, it's about the same. This effect is then similarly lapped as we move into 2025. Finally, there's a price down on a large state eligibility program that started to take effect here in Q2 contributing around 1.5 points of revenue decline in the quarter. It will be two points to three points of decline per quarter as compared to prior year until we lap this effect midway through Q2 2025. Just so that you can complete the math on this one there's about a point of all other growth in Q3 revenue and three points of growth assumed in Q4 both as compared to prior year and that will get you to an overall 9% down in Q2 and an expected 11% to 12% down in Q3 and 6% to 7% down in Q4 against prior year compares with only the price down on the large state program having any annualization of impact into 2025. Overall, this adjusts our full year expected outcome for government revenue to be down about 7.5% 2024 versus 2023. We previously expected to be able to make up some of this with new business. However, as previously discussed sales performance has lagged expectations so far this year and so the revenue from new business in the government segment will likely now manifest in 2025. It's important to reiterate it's driven by a few items and absenting these we feel good about the base revenue with a lot of pipeline opportunity to convert in front of us. The government segment makes up a disproportionate amount of our forward pipeline of $4.2 billion of ACV. Adjusted EBITDA for the government segment in Q2 2024 was $49 million down 36% year-over-year. The above mentioned three discrete items are again most of what drives this as well as some short term elevated expenses related to a couple of implementations in flight that should normalize later in the year. Transportation segment adjusted revenues in Q2, 2024 were $141 million up 1. 4% year-over-year. The implementation ramp from our large transit project in Australia was $22 million. However, almost completely offset by a long anticipated reduction in scope and pricing adjustment for our large long-term clients in our tolling business. For the Transportation segment, adjusted EBITDA for the quarter was $3 million as compared to $9 million in Q2 2023 and the adjusted EBITDA margin was 2.1%. The primary driver here was revenue mix specifically between the two contracts noted previously and partially offset by improved operational performance. There's been a margins reset within transportation because of the divestiture of the curbside and public safety businesses and this is one area where we have several initiatives underway to remove stranded costs, drive incremental operating efficiency and continue to build scale back into our tolling and transit businesses. In the next couple of quarters, you are going to see EBITDA margin in this sort of range, absenting any effect from discrete items, but our path forward is the levers that I highlighted above and these should drive incremental improvement as we progress through 2025. Let's turn to Slide 10 and discuss the balance sheet and cash flow. We ended the quarter with approximately $307 million of total cash on balance sheet and our $550 million revolving credit facility was largely undrawn at the end of the quarter. In the quarter, we made payments on debt of $328 million including voluntarily prepaying $300 million on our term loan B. We have additional authority to repay debt up to $200 million from future divestiture proceeds, which would deal with our near and midterm maturities. In the quarter, we deployed approximately $150 million in repurchasing 43.3 million shares at an average price of $3.46. This included the opportunity to repurchase all the shares owned by Carl Icahn through certain of his affiliates for an approximate aggregate purchase price of $132 million. You've seen from our walk on how we've deployed the $1 billion of capital that we think our steady state cash need in the business is somewhere around the $350 million mark. We ended the quarter a little bit below that because of the opportunity to enter into the repurchase of the Icahn shares. If we look forward over the coming quarters, we're expecting to receive net proceeds of approximately $200 million in relation to the expected closure of the sale of the Casualty Claims Solutions business and an additional $61 million of deferred purchase consideration on the sale of our curbside and public safety businesses. The combination then of the stronger outlook in the second half of the year on operating cash flow as we reach several important billing milestones on some large contracts as well as the inflows from our divestiture program has us in good shape to continue to prepay debt as desired, manage our leverage and maintain our desired level of liquidity. Our net leverage decreased to 1.7 turns below our previous target range of 2 turns to 2.5 turns. You'll see in our exit rate outlook for 2025 our medium term target considering some additional debt prepayment is around 1 turn of net leverage. Capital expenditure in the Q2 was 3.6% of revenue and we expect to be at about 3% of revenue or slightly below that for full year 2024. Let's turn now to Slide 11 and cover our outlook for 2024. You heard me say earlier that within the government segment we expect the revenue decline to be in the 7% to 8% range for 2024, but overall, I'd say that we're still above the midpoint of our original guide on revenue for 2024 had we not divested the two businesses with commercial and transportation doing slightly better and for EBITDA, again as I said earlier, my sense is that we'd be somewhere around the lower end of the guided range we laid out then about 8% without taking out these divested businesses. As you now look at our adjusted outlook on the page here, you'll see that the basis for our guidance has been restated to adjust for the two closed divestitures. We expect full year adjusted revenue to be in the range of $3.325 billion to $3.375 billion at the midpoint that's about 3% down year-over-year and we expect adjusted EBITDA margin to be in the range of 4% to 5% with sequential improvement from Q2 hereon. We expect these ranges to be further adjusted in our Q3 earnings for the anticipated close of the Casualty Claims Solutions business, which will equate to approximately $150 million of revenue and about one point of reduction in EBITDA margin. In terms of some of our other modeling considerations, we expect adjusted free cash flow as a percentage of adjusted EBITDA to be around zero. This is due to the loss of the adjusted EBITDA from the divested businesses from the point of closure partially offset with cost efficiency work and a substantial reduction in our interest expense. To reiterate, this is not a fully adjusted metric. We don't break out discrete cash flows at the level of these divested assets. So we've moved it down in the table here and are removing it from our fully adjusted guide for the time being to present it as an additional modeling consideration. Finally, you'll see CapEx reducing here with the effect of the divestitures with more to come when we complete the expected Casualty Claims Solutions divestiture in the third quarter. Moving on to Slide 12, this continues to be an important view giving you a walk to that exit rate in 2025 and remains how we think about the journey we're on over the next 18 months or so. You will notice that we've added incremental detail here to complete the 2025 exit rate view. We've also made some minor adjustments to this walk. Firstly, we've reduced the divested revenue from $500 million to $450 million to account for some revenue streams that we've retained from the three announced divestitures versus those originally contemplated. The three announced transactions account for approximately $400 million of divested revenue and the loss of EBITDA from these three divested businesses is approximately $135 million. With more clarity related to the proceeds from the three announced divestitures and more specifically a reduction in the anticipated tax drag, we're increasing the net proceeds from the three announced transactions to $750 million an increase of $50 million and in the upper quartile of our targeted range of $600 million to $800 million of after tax proceeds. We've refined our margin expansion assumption to be in the range of 2% to 2.5% reflecting certain expected pricing and contractual outcomes on a large federal contract renewal within our government payments business. Many of you will know, we run the card processing for the Federal Government Direct Express Program on behalf of a large regional bank. It's been informally reported that this contract is being negotiated with another bank and processing vendor and that negotiations will continue through this year. At this stage, we have not included this as a notified loss in our net ARR metric for the full year 2024. As we understand that the notification was both informal and preliminary nor does it adjust our 2025 revenue outlook as we minimally expect to have this revenue into 2026 given the likely long transition timeline needed to move this complex program that we've run for over 15 years. At this point, the margin refinement in our walk removes the incremental pricing we intended to achieve on this renewal in order to make this contract attractive for us to retain. For size, it's approximately $100 million of revenue and is very marginally profitable and dilutive to the government segment as currently priced. Our capital allocation plans include an additional $200 million of Board authority to prepay debt. Over time as EBITDA recovers sequentially, this will drive our net leverage ratio towards our new target range of approximately one term. Interest expense will be approximately $38 million on $600 million to $700 million of debt and this results in an adjusted free cash flow range of between 25% 30%. The strength of our sales pipeline and proven programmatic approach to cost reduction already underway gives us confidence to remain convicted in achieving these 2025 exit rate targets as well as our ability to generate and deploy the $1 billion of which 66% is already deployed. In terms of Q3, adjusted for the two divestitures completed, we are expecting adjusted revenue to be in the range of $815 million to $825 million and we would expect to see a sequential improvement in adjusted EBITDA margin for the third quarter to be in the range of 3.75% to 4.25% as we continue our work on our cost efficiency programs and remove stranded costs. That concludes my financial remarks for the quarter and I'll hand it back over to Cliff for the broader business update because there's a lot going on there as well. Cliff?